An online tool for improving biospecimen data element reporting

Biopreservation and Biobanking

Volumn 10, Issue 6, 2012, Pages 501-510

  Cheah, Stefanie ^a,b   Dee, Simon ^a,b   Cole, Alexandra ^c   Matzke, Lise ^b   O'Donoghue, Sheila ^a,b   Watson, Peter H ^a,b,c  

^a BC BioLibrary   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BIOSPECIMEN; HUMAN; INFORMATION PROCESSING; ONLINE SYSTEM; PRESERVATION AND STORAGE; PRIORITY JOURNAL; RESEARCH ETHICS; STANDARD; CANADA; HEALTH CARE FACILITY; MEDICAL RESEARCH; METHODOLOGY; NEOPLASM; PATHOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA; WEB BROWSER;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; CANADA; HUMANS; NEOPLASMS; RESEARCH DESIGN; WEB BROWSER;

EID: 84870719993     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2012.0033     Document Type: Article

References (14)

1. Grizzle WE, Bell WC, Sexton KC. Issues in collecting, processing and storing human tissues and associated information to support biomedical research. Cancer Biomarkers 2011;9: 531-549.
2. Barnes RO, Parisien M, Murphy LC, et al. Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev 2008;17: 3344-3350.
3. Engel KB, Moore HM. Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med 2011;135: 537-543.
4. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005;97: 1180-1184.
5. Betsou F, Lehmann S, Ashton G, et al. Standard preanalytical coding for biospecimens: Defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev 2010;19: 1004-1011.
6. Moore HM, Kelly A, Jewell SD, et al. Biospecimen reporting for improved study quality. Biopreserv Biobank 2011;9: 57-70.
7. Equator Network. 2011 [cited 2012 May 30, 2012]; Available from: http:/www.equator-network.org. Last accessed 15 November 2012.
8. Hughes SE, Watson PH. Biospecimen use in cancer research over two decades. Biopreserv Biobank 2010;8: 89-97.
9. Riegman PH, Morente MM, Betsou F, et al. Biobanking for better healthcare. Mol Oncol 2008;2: 213-222.
10. Betsou F, Barnes R, Burke T, et al. Human biospecimen research: Experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 2009;18: 1017-1025.
11. Simeon-Dubach D, Perren A. Better provenance for biobank samples. Nature 2011;475: 454-455.
12. Lim MD, Dickherber A, Compton CC. Before you analyze a human specimen, think quality, variability, and bias. Anal Chem 2011;83: 8-13.
13. Hemingway H, Philipson P, Chen R, et al. Evaluating the quality of research into a single prognostic biomarker: A systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med 2010;7(6):e1000286.
14. Mallett S, Timmer A, Sauerbrei W, et al. Reporting of prognostic studies of tumour markers: A review of published articles in relation to REMARK guidelines. Br J Cancer 2010;102: 173-180.